Trademark: 97036217
Status Date
Monday, April 3, 2023
Filing Date
Monday, September 20, 2021
Published for Opposition
Tuesday, July 5, 2022
Abandoned Date
Monday, April 3, 2023
5 Pharmaceutical preparations for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations for the prevention and treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations for the prevention and treatment of Parkinson's disease and disorder; pharmaceutical preparations for the prevention and treatment of dizziness and lightheadedness
Apr 3, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 3, 2023
Abandonment - No Use Statement Filed
Aug 30, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 5, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 5, 2022
Published For Opposition
Jun 15, 2022
Notification Of Notice Of Publication E-Mailed
May 28, 2022
Assigned To Lie
May 26, 2022
Approved For Pub - Principal Register
May 26, 2022
Examiner's Amendment Entered
May 26, 2022
Notification Of Examiners Amendment E-Mailed
May 26, 2022
Examiners Amendment E-Mailed
May 26, 2022
Examiners Amendment -Written
May 23, 2022
Previous Allowance Count Withdrawn
May 17, 2022
Withdrawn From Pub - Og Review Query
May 3, 2022
Approved For Pub - Principal Register
Apr 27, 2022
Assigned To Examiner
Oct 24, 2021
New Application Office Supplied Data Entered
Sep 23, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
